Efalizumab for severe atopic dermatitis: a pilot study in adults.
about
Personalized Immunomodulatory Therapy for Atopic Dermatitis: An Allergist's ViewBiological Treatments in Atopic DermatitisNew insights into T cell biology and T cell-directed therapy for autoimmunity, inflammation, and immunosuppressionTreatment of severe atopic dermatitis with a combination of subcutaneous allergen immunotherapy and cyclosporin.What's new in dermatologic therapy.Biologics in dermatology.Emerging biologics in the treatment of uveitis.Guidelines for treatment of atopic eczema (atopic dermatitis) Part II.Immunology of atopic eczema: overcoming the Th1/Th2 paradigm.EAACI IG Biologicals task force paper on the use of biologic agents in allergic disorders.Past, present, and future for biologic intervention in atopic dermatitis.Circulating CLA+ T cells in atopic dermatitis and their possible role as peripheral biomarkers.Systemic immune mechanisms in atopic dermatitis and psoriasis with implications for treatment.Eczematous dermatosis and thrombocytosis induced by efalizumab: two new side effects.Clinical and immunological changes of immunotherapy in patients with atopic dermatitis: randomized controlled trial.Monoclonal Antibodies for Atopic Dermatitis: Progress and Potential.Repetitive immunoadsorption cycles for treatment of severe atopic dermatitis.
P2860
Q26798373-9EBD9F69-736E-4C82-A2FE-97FED5237ED2Q26799579-7F124D1D-BB67-4DC3-89E5-D8101A1E4E68Q34175958-8E15A340-D61C-47BC-8906-136737E8B7EDQ35648296-52588D3D-57A7-4C3F-A477-DF78B6147F64Q37131029-F85D55DF-A64F-4CC3-A093-024C71B67C25Q37277398-71538A33-6082-4F2D-A115-8F24D1A708D5Q37754665-0855EA7D-5F58-42B4-86E1-1FEC4FCAE8FEQ38027604-2B9CDDD0-4681-41A7-AF87-2E91CB75783AQ38124385-0DCDC4DF-0679-4D59-923F-99C670333D89Q38394577-83BF60DD-5F97-429C-9860-0B406E1AC8C2Q38423474-58B08305-E536-4790-A74F-2A88C7119C9EQ38793743-98BFD673-0ED8-4F8B-8D70-727056CDD805Q39165518-F9A53373-9FBD-4E2C-9109-3F2D7B5C0FF4Q40415407-9A91C255-B1D9-4EF8-9DA3-88AB7624B3E2Q40842862-026499B0-EF99-4571-BA9A-BD7157A0AF14Q47720341-AF4243E4-039B-470D-BF31-3DD923F88BE7Q53667719-AAD1E3DA-C521-42A2-89CF-1C8D1BDAFA68
P2860
Efalizumab for severe atopic dermatitis: a pilot study in adults.
description
2006 nî lūn-bûn
@nan
2006 թուականի Հոկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հոտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@ast
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@en
type
label
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@ast
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@en
prefLabel
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@ast
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@en
P2093
P1476
Efalizumab for severe atopic dermatitis: a pilot study in adults.
@en
P2093
Andrew Blauvelt
Brenda Simpson
Eric Simpson
Erin Harper
Jon Hanifin
Rodd Takiguchi
Susan Tofte
P304
P356
10.1016/J.JAAD.2006.08.031
P407
P577
2006-10-13T00:00:00Z